Riskpilot← Back to searchSign inGet full accessTCIT EUROPE AS
ASActiveOrg 930821802Dr. Palmstrøms Vei 15, 9901 KirkenesWholesale of pharmaceutical and medical goods · NACE 4646Est. 20230 employees
Revenue 2025
NOK 0
EBITDA margin
—
-22% vs 2024
Equity ratio
-189.9%
Financial strength
Net profit 2025
NOK -45K
-21% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -45K | -22% |
| Net profit | NOK -45K | -21% |
| Total assets | NOK 11K | -58% |
| Equity | NOK -21K | -187% |
| Employees | 0 | — |
Legal name
TCIT EUROPE AS
Org number
930821802
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14. februar 2023
Share capital
NOK 103 318
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Medisinsk forskning og utvikling samt salg og formidling av medisinsk utstyr og teknologi. Videre skal selskapets virksomhet kunne være - direkte og/eller indirekte - å investere i verdipapirer og alt som er beslektet eller står i forbindelse med slik virksomhet. Selskapet skal også kunne eie - helt eller delvis - eller delta i selskaper eller næringsforetak som driver annen virksomhet.
Address
Dr. Palmstrøms Vei 15, 9901 Kirkenes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 |
| EBITDA | −38 | −37 | −45 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | −38 | −37 | −45 |
| Net financials | 1 | −0 | 0 |
| Profit before tax | −37 | −37 | −45 |
| Tax | −0 | −0 | −0 |
| Net profit | −37 | −37 | −45 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 63 | 26 | 11 |
| Equity | 61 | 24 | −21 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 2 | 2 | 32 |
| Total debt | 2 | 2 | 32 |
EBITDA margin
-4489600.0%
This company
15.8%
Market median
-28415290% vs market
20232025
Equity ratio
-189.9%
This company
38.2%
Market median
-597% vs market
20232025
Return on equity
-4489600.0%
This company
18.4%
Market median
-24400100% vs market
20232025
Net profit margin
-4489600.0%
This company
8.1%
Market median
-55427260% vs market
20232025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232025
Debt / equity
1.53×
This company
0.62×
Market median
-147% vs market
20232025
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
YZ Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Taiwan Colour And Imaging Technolog | Company | 66.67% | 66.67% | 2023 |
| Company | 33.33% | 33.33% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TCIT EUROPE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Yingxiang Zhao | Chief Executive Officer | 0 companies |
| Pål Lund-Roland | Board of Directors | 0 companies |
| Chi-An Shaw | Chairman | 0 companies |